Ulcerative Colitis: Correlation of the Rachmilewitz Endoscopic Activity Index with Fecal Calprotectin, Clinical Activity, C-reactive Protein, and Blood Leukocytes

被引:268
|
作者
Schoepfer, Alain M. [1 ,2 ]
Beglinger, Christoph [3 ]
Straumann, Alex [3 ]
Trummler, Michael [4 ]
Renzulli, Pietro [5 ]
Seibold, Frank [2 ]
机构
[1] McMaster Univ, Farncombe Family Inst Digest Hlth Res, Hamilton, ON L8N 3Z5, Canada
[2] Univ Hosp Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland
[3] Univ Basel Hosp, Dept Gastroenterol, CH-4031 Basel, Switzerland
[4] Bioanalyt Med Labs, Luzern, Switzerland
[5] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland
基金
瑞士国家科学基金会;
关键词
fecal calprotectin; ulcerative colitis; biomarkers; disease activity; Rachmilewitz Activity Index; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; 5-AMINOSALICYLIC ACID; SURROGATE MARKERS; COLORECTAL-CANCER; RELAPSE; RISK; CRP; PERFORMANCE; PARAMETERS;
D O I
10.1002/ibd.20986
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The accuracy of noninvasive markers for the detection of endoscopically active ulcerative colitis (UC) according the Rachmilewitz Score is so far unknown. The aim was to evaluate the correlation between endoscopic disease activity and fecal calprotectin. Clinical Activity Index, C-reactive protein (CRP), and blood leukocytes. Methods: UC patients undergoing colonoscopy were prospectively enrolled and scored independently according the endoscopic and clinical part of the Rachmilewitz Index. Patients and controls provided fecal and blood samples for measuring calprotectin, CRP, and leukocytes. Results: Values in UC patients (n = 134) compared to controls (n = 48): calprotectin: 396 +/- 351 versus 18.1 +/- 5 mu g/g, CRP 16 +/- 13 versus 3 +/- 2 mg/L, blood leukocytes 9.9 +/- 3.5 versus 5.4 +/- 1.9 g/L (all P < 0.001). Endoscopic disease activity correlated closest with calprolectin (Spearman's rank correlation coefficient r = 0.834), followed by Clinical Activity Index (r = 0.672), CRP (r = 0.503), and leukocytes (r = 0.461). Calprotectin levels were significantly lower in UC patients with inactive disease (endoscopic score 0-3, calprotectin 42 +/- 38 mu g/g), compared to patients with mild (score 4-6, calprotectin 210 +/- 121 mu g/g, P < 0.001), moderate (score 7-9, calprotectin 392 +/- 246 mu g/g, P = 0.002), and severe disease (score 10-12, calprotectin 730 +/- 291 mu g/g, P < 0.001). The overall accuracy for the detection of endoscopically active disease (score >4) was 89% for calprotectin, 73% for Clinical Activity Index, 62% for elevated CRP, and 60% for leukocytosis. Conclusions: Fecal calprotectin correlated closest with endoscopic disease activity, followed by Clinical Activity Index, CRP, and blood leukocytes. Furthermore, fecal calprotectin was the only marker that reliably discriminated inactive from mild, moderate, and highly active disease, which emphasizes its usefulness for activity monitoring.
引用
收藏
页码:1851 / 1858
页数:8
相关论文
共 50 条
  • [1] Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes
    Schoepfer, Alain M.
    Beglinger, Christoph
    Straumann, Alex
    Safroneeva, Ekaterina
    Romero, Yvonne
    Armstrong, David
    Schmidt, Carsten
    Trummler, Michael
    Pittet, Valerie
    Vavricka, Stephan R.
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) : 332 - 341
  • [2] Correlation of C-Reactive Protein with Clinical and Endoscopic Activity in Patients with Ulcerative Colitis
    Sami Karoui
    Sonia Laz
    Meriem Serghini
    Norsaf Bibani
    Jalel Boubaker
    Azza Filali
    [J]. Digestive Diseases and Sciences, 2011, 56 : 1801 - 1805
  • [3] Correlation of C-Reactive Protein with Clinical and Endoscopic Activity in Patients with Ulcerative Colitis
    Karoui, Sami
    Laz, Sonia
    Serghini, Meriem
    Bibani, Norsaf
    Boubaker, Jalel
    Filali, Azza
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) : 1801 - 1805
  • [4] CORRELATION OF FECAL CALPROTECTIN AND C-REACTIVE PROTEIN CONCENTRATIONS WITH CLINICAL OUTCOMES AND ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING INDUCTION THERAPY WITH ETRASIMOD
    Yarur, Andres J.
    Jairath, Vipul
    Zhang, Jinkun
    Panes, Julian
    Chiorean, Michael V.
    Peyrin-Biroulet, Laurent
    Vermeire, Severine
    Cabell, Chris
    Naik, Snehal
    Sandborn, William J.
    [J]. GASTROENTEROLOGY, 2019, 156 (06) : S1108 - S1109
  • [5] Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis Than the Lichtiger Index, CRP or Blood Leukocytes
    Schoepfer, Alain
    Beglinger, Christoph
    Straumann, Alex
    Safroneeva, Ekaterina
    Romero, Yvonne
    Armstrong, David
    Schmidt, Carsten
    Trummler, Michael
    Pittet, Valerie
    Vavricka, Stephan R.
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S114 - S114
  • [6] Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis
    Tarang Taghvaei
    Iradj Maleki
    Farshad Nagshvar
    Hafez Fakheri
    Vahid Hosseini
    Seyed Mohammad Valizadeh
    Hassan Neishaboori
    [J]. Internal and Emergency Medicine, 2015, 10 : 321 - 328
  • [7] Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis
    Taghvaei, Tarang
    Maleki, Iradj
    Nagshvar, Farshad
    Fakheri, Hafez
    Hosseini, Vahid
    Valizadeh, Seyed Mohammad
    Neishaboori, Hassan
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2015, 10 (03) : 321 - 328
  • [8] Assessing the Correlation of Fecal Calprotectin and the Clinical Disease Activity Index in Patients With Ulcerative Colitis
    Amiriani, Taghi
    Besharat, Sima
    Dadjou, Mohammad
    Roshandel, Gholamreza
    Mirkarimi, HoneySadat
    Salamat, Faezeh
    Joshaghani, Hamidreza
    [J]. GASTROENTEROLOGY NURSING, 2018, 41 (03) : 201 - 205
  • [9] Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, CRP, platelets, hemoglobin, and blood leukocytes
    Schoepfer, Alain
    Beglinger, Christoph
    Straumann, Alex
    Safroneeva, Ekaterina
    Trummler, Michael
    Pittet, Valerie
    Vavricka, Stephan R.
    [J]. SWISS MEDICAL WEEKLY, 2012, 142 : 7S - 7S
  • [10] Fecal Calprotectin, C-Reactive Protein and Clinical Activity During Infliximab Induction Therapy
    Lonnkvist, Maria
    Befrits, Ragnar
    Ljung, Tryggve
    Holst, Mikael
    Hellstrom, Per M.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S556 - S557